- Home
- GITS vs ISPC Comparison
GITS vs ISPC Comparison
Compare GITS & ISPC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | GITS | ISPC |
|---|---|---|
| Founded | 2018 | 2009 |
| Country | South Korea | United States |
| Employees | N/A | N/A |
| Industry | | Precision Instruments |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.7M | 5.7M |
| IPO Year | N/A | 2021 |
Fundamental Metrics
Financial Performance| Metric | GITS | ISPC |
|---|---|---|
| Price | $1.23 | $0.47 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 15.3K | ★ 442.5K |
| Earning Date | 11-12-2025 | 11-17-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $1,867.00 | ★ $3,352,744.00 |
| Revenue This Year | N/A | $35.93 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.87 | $0.39 |
| 52 Week High | $9.78 | $4.66 |
Technical Indicators
Market Signals| Indicator | GITS | ISPC |
|---|---|---|
| Relative Strength Index (RSI) | 30.23 | 38.31 |
| Support Level | $1.17 | $0.39 |
| Resistance Level | $1.31 | $0.69 |
| Average True Range (ATR) | 0.09 | 0.08 |
| MACD | 0.01 | 0.01 |
| Stochastic Oscillator | 18.60 | 29.65 |
Price Performance
Historical ComparisonAbout GITS Global Interactive Technologies Inc. Common Stock
Global Interactive Technologies Inc, formerly Hanryu Holdings Inc is the creator of the engaging social media platform, FANTOO. Through FANTOO, it provides a multi-media platform for its users to interact with other like-minded users, share their appreciation of various types of entertainment and cultures, create their content, enjoy content, and engage in commerce.
About ISPC iSpecimen Inc.
iSpecimen Inc is a technology-driven company focused on connecting life science researchers who need human biofluids, solid tissues, and hematopoietic stem and immune cells for their research, with the available biospecimens. The company generates revenue by procuring various specimens from hospitals, laboratories, and other supply sites. Geographically, it has a presence in the Americas; Europe, the Middle East, Africa, and Asia Pacific, which majority, comes from the Americas.